Home > Insider Trading > Filing (0001104659-20-000978)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1264587	Stemline Therapeutics Inc	STML	Pharmaceutical Preparations (2834)	450522567

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1554767	Ivan Bergstein	C/O Stemline Therapeutics, Inc. 750 Lexington Avenue, Eleventh Floor New York NY 10022	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2019-12-23	5,225	$10.58	2,565,576	No	4	S	Direct
Common Stock	Disposition	2019-12-24	29,613	$10.97	2,535,963	No	4	S	Direct
Common Stock	Disposition	2019-12-26	18,744	$10.75	2,517,219	No	4	S	Direct
Common Stock	Disposition	2019-12-27	2,446	$10.48	2,514,773	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

In connection with the vesting of 108,505 shares on December 21, 2019, a total of 56,028 shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies. 5,225 shares were sold on December 23, 2019; 29,613 shares were sold on December 24, 2019; 18,744 shares were sold on December 26, 2019; and 2,446 shares were sold on December 27, 2019.
Reflects the weighted average sale price. The range of prices for the shares sold on December 23, 2019 was $10.37 to $10.75; the range of prices for the shares sold on December 24, 2019 was $10.81 to $11.15; the range of prices for the shares sold on December 26, 2019 was $10.52 to $11.20; and the range of prices for the shares sold on December 27, 2019 was $10.34 to $10.76. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Of the shares listed, 578,695 shares are restricted stock.